Pan-Cancer 1 (EGFR, KRAS, NRAS, BRAF, IDH1) Crystal Digital PCR® Assay
Assay-specific Crystal Flex Probes and primers for the detection of EGFR, KRAS, NRAS, BRAF, and IDH1 mutations and its Positive Control.
For Research Use Only. Not for use in diagnostic procedures.
Compatibility
Channels
Required Reagents
The Pan-Cancer1 (EGFR, KRAS, NRAS, BRAF, IDH1) Crystal Digital PCR® Assay is a 10X assay designed to detect and quantify mutations in multiple genes using the Ruby Chip. These genes play major roles in regulating cell signaling pathways, and their mutations drive tumor development. Numerous targeted therapies are available, in which mutation identification and monitoring is the key to selecting the right therapeutic approach.
This assay is available in 200 and 1000 reaction formats.
Ready-to-use assay reagents to detect multiple targets in a single reaction
Crystal Flex Probe detection chemistry for flexible assay configuration
Same set of Crystal Universal Reporters to detect any target in different assays
High multiplexing with low price per point
EGFR deletion exon 19/L858R
KRAS G12C/G12D
NRAS Q61R
BRAF V600E
IDH1 R132H
Ready-to-use assays & kits
Explore our catalogue of assays and kits and take a leap into the world of multiplexing. Crystal Digital PCR® assays and kits allow for the detection of multiple targets of interests within one single Ruby Chip chamber.
Rapid high-plex assay customization
Stilla offers the fastest assay design service in the market for multiplexed digital PCR assays. Stilla exploits its proprietary Crystal Flex Probe PCR chemistry to offer customized assays in record time, at competitive prices.
